Altogether, these findings suggest that BCG vaccination in K18-ACE2 mice activates glycolysis, which is critical for BCG-induced trained immunity (43) that may offer protection to the infection of SARS-CoV-2 and SARS-CoV-2 variants in K18-ACE2 mice. This evidence concerns the gene KRT18 and infection.